Literature DB >> 14705150

Down-regulation of caveolin-1 in glioma vasculature: modulation by radiotherapy.

Anthony Régina1, Julie Jodoin1, Paul Khoueir1, Yannève Rolland1, France Berthelet2, Robert Moumdjian2, Laurence Fenart3, Romeo Cecchelli3, Michel Demeule1, Richard Béliveau1.   

Abstract

Primary brain tumors, particularly glioblastomas (GB), remain a challenge for oncology. An element of the malignant brain tumors' aggressive behavior is the fact that GB are among the most densely vascularized tumors. To determine some of the molecular regulations occuring at the brain tumor endothelium level during tumoral progression would be an asset in understanding brain tumor biology. Caveolin-1 is an essential structural constituent of caveolae that has been implicated in mitogenic signaling, oncogenesis, and angiogenesis. In this work we investigated regulation of caveolin-1 expression in brain endothelial cells (ECs) under angiogenic conditions. In vitro, brain EC caveolin-1 is down-regulated by angiogenic factors treament and by hypoxia. Coculture of brain ECs with tumoral cells induced a similar down-regulation. In addition, activation of the p42/44 MAP kinase is demonstrated. By using an in vivo brain tumor model, we purified ECs from gliomas as well as from normal brain to investigate possible regulation of caveolin-1 expression in tumoral brain vasculature. We show that caveolin-1 expression is strikingly down-regulated in glioma ECs, whereas an increase of phosphorylated caveolin-1 is observed. Whole-brain radiation treatment, a classical way in which GB is currently being treated, resulted in increased caveolin-1 expression in tumor isolated ECs. The level of tumor cells spreading around newly formed blood vessels was also elevated. The regulation of caveolin-1 expression in tumoral ECs may reflect the tumoral vasculature state and correlates with angiogenesis kinetics. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14705150     DOI: 10.1002/jnr.10865

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

1.  Caveolin-1 regulates expression of junction-associated proteins in brain microvascular endothelial cells.

Authors:  Li Song; Shujun Ge; Joel S Pachter
Journal:  Blood       Date:  2006-10-05       Impact factor: 22.113

2.  Caveolin expression changes in the neurovascular unit after juvenile traumatic brain injury: signs of blood-brain barrier healing?

Authors:  J Badaut; D O Ajao; D W Sorensen; A M Fukuda; L Pellerin
Journal:  Neuroscience       Date:  2014-11-04       Impact factor: 3.590

3.  Temozolomide modifies caveolin-1 expression in experimental malignant gliomas in vitro and in vivo.

Authors:  Céline Bruyère; Laurence Abeloos; Delphine Lamoral-Theys; Rebecca Senetta; Véronique Mathieu; Marie Le Mercier; Richard E Kast; Paola Cassoni; Guy Vandenbussche; Robert Kiss; Florence Lefranc
Journal:  Transl Oncol       Date:  2011-04-01       Impact factor: 4.243

4.  Altered angiogenesis in caveolin-1 gene-deficient mice is restored by ablation of endothelial nitric oxide synthase.

Authors:  Christudas Morais; Quteba Ebrahem; Bela Anand-Apte; Marie-Odile Parat
Journal:  Am J Pathol       Date:  2012-02-07       Impact factor: 4.307

5.  Overexpression of caveolin-1 in lymphoblastoid TK6 cells enhances proliferation after irradiation with clinically relevant doses.

Authors:  David Barzan; Patrick Maier; W Jens Zeller; Frederik Wenz; Carsten Herskind
Journal:  Strahlenther Onkol       Date:  2010-01-28       Impact factor: 3.621

Review 6.  Brain endothelial cells as pharmacological targets in brain tumors.

Authors:  Michel Demeule; Anthony Régina; Borhane Annabi; Yanick Bertrand; Michel W Bojanowski; Richard Béliveau
Journal:  Mol Neurobiol       Date:  2004-10       Impact factor: 5.590

7.  Caveolin-1 is critical for the maturation of tumor blood vessels through the regulation of both endothelial tube formation and mural cell recruitment.

Authors:  Julie Dewever; Françoise Frérart; Caroline Bouzin; Christine Baudelet; Réginald Ansiaux; Pierre Sonveaux; Bernard Gallez; Chantal Dessy; Olivier Feron
Journal:  Am J Pathol       Date:  2007-10-04       Impact factor: 4.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.